TransAct Technologies Incorporated TACT
4.87
(0.04)
(0.81%)
as of 25 Sep
- Market cap
- $50.7M
- P/E
- 0.0×
Follow TACT
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.09 | 0.78 | 0.63 | 1.13 | |
P/FCF ratio |
6.84 | 6.66 | 7.09 | 34.24 | |
P/Operating CF |
15.08 | 66.25 | (35.40) | 27.88 | |
P/B ratio |
1.72 | 1.30 | 1.04 | 1.84 | |
Price to Tangible BV |
1.97 | 1.49 | 1.21 | 2.26 | |
EV/Sales |
0.71 | 0.41 | 0.30 | 0.79 | |
EV/EBITDA |
0.00 | 0.00 | 557.49 | 209.38 | |
EV/Operating CF |
3.78 | 2.72 | 2.27 | 7.65 | |
EV/FCF |
4.46 | 3.45 | 3.30 | 23.74 | |
Quick Ratio |
2.02 | 2.05 | 2.25 | 1.94 | |
Current Ratio |
3.05 | 2.97 | 3.13 | 2.65 | |
Net Debt/EBITDA |
(113.23) | 20.62 | (20.28) | (230.80) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.05 | 1.16 | 1.15 | 1.11 | |
Operating CF/Net income |
242.00 | (0.54) | (1.23) | (43.10) | |
Capex/Depreciation |
(8.66) | (1.04) | (3.54) | (11.23) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
12.57% | 14.71% | 9.57% | 8.79% | |
Selling, General and Administrative Expense of Revenue |
37.08% | 42.95% | 35.39% | 41.80% | |
Intangible Assets out of Total Assets |
0.09 | 0.09 | 0.10 | 0.12 | |
Share Based Compensation of Revenue |
4.00% | 4.38% | 3.54% | 3.26% | |
Graham Net Nets |
0.47 | 0.62 | 0.69 | 0.37 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(14.77%) | (3.02%) | (1.30%) | (0.57%) | |
Free Cash Flow Yield |
14.61% | 15.02% | 14.11% | 2.92% | |
Revenue per Share |
1.30 | 1.14 | 1.42 | 1.36 | |
Operating CF per Share |
0.36 | 0.06 | (0.09) | 0.21 | |
Capex per Share |
(0.14) | (0.02) | (0.05) | (0.15) | |
Free Cash Flow per Share |
0.22 | 0.04 | (0.15) | 0.06 | |
Cash per Share |
1.98 | 2.03 | 1.85 | 1.88 | |
Shareholders Equity per Share |
3.15 | 3.08 | 3.17 | 3.18 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.15 | 3.08 | 3.17 | 3.18 | |
Free Cash Flow |
2.22 | 0.44 | (1.51) | 0.61 | |
Working Capital |
26.33 | 25.76 | 26.34 | 25.27 | |
Capital Expenditures |
(1.41) | (0.17) | (0.56) | (1.55) | |
Net Current Asset Value |
25.95 | 25.16 | 23.11 | 22.22 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.11 | 0.01 | 0.04 | 0.11 | |
Net Profit Margin |
0.11% | (9.88%) | 5.31% | (0.36%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
6.63 | 6.44 | 9.04 | 9.08 | |
Average Payables |
3.46 | 4.05 | 4.54 | 4.48 | |
Average Inventory |
14.29 | 13.51 | 11.99 | 11.03 | |
Average Assets |
47.74 | 44.40 | 46.03 | 47.79 | |
Average Common Equity |
35.07 | 30.87 | 31.61 | 31.98 |
Columns are period end dates